Raphael Mohr
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Hepatology 21
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Liver Disease and Transplantation 7
- Hepatitis C virus research 6
- Oncology 19
- Cancer Immunotherapy and Biomarkers 9
- Lung Cancer Research Studies 5
- Co-authors
- Frank Tacke (30 shared papers)Christoph Roderburg (29 shared papers)Jürgen K. Rockstroh (9 shared papers)Ulrich Spengler (7 shared papers)Christian P. Strassburg (9 shared papers)Maria A. González-Carmona (9 shared papers)Tom Luedde (16 shared papers)Jonel Trebicka (8 shared papers)
In The Last Decade
Raphael Mohr
65 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 74
- Hepatology 232
- Oncology 247
- Immunology 162
- Epidemiology 243
- Cancer Research 105
Countries citing papers authored by Raphael Mohr
This map shows the geographic impact of Raphael Mohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Mohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Mohr more than expected).
Fields of papers citing papers by Raphael Mohr
This network shows the impact of papers produced by Raphael Mohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Mohr. The network helps show where Raphael Mohr may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael Mohr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 120 | |
| 2 | 2019 | 54 | |
| 3 | 2021 | 48 | |
| 4 | 2014 | 48 | |
| 5 | 2021 | 39 | |
| 6 | 2023 | 36 | |
| 7 | 2015 | 36 | |
| 8 | 2020 | 34 | |
| 9 | High-dose MTX/5-FU and adriamycin for gastric cancer. | 1983 | 34 |
| 10 | 2023 | 30 | |
| 11 | 2018 | 28 | |
| 12 | 1974 | 27 | |
| 13 | 2020 | 26 | |
| 14 | 2021 | 24 | |
| 15 | 2021 | 24 | |
| 16 | 2021 | 23 | |
| 17 | 2020 | 23 | |
| 18 | 2021 | 17 | |
| 19 | 2018 | 17 | |
| 20 | 2023 | 16 |
About Raphael Mohr
Raphael Mohr is a scholar working on Hepatology, Oncology, Epidemiology, Surgery and Pulmonary and Respiratory Medicine, having authored 73 papers that have together received 1.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Liver Disease and Transplantation (7 papers), Hepatitis C virus research (6 papers), Lung Cancer Research Studies (5 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Hepatology (232 citations), Oncology (247 citations), Immunology (162 citations), Epidemiology (243 citations) and Cancer Research (105 citations). Raphael Mohr has collaborated with scholars based in Germany, Spain and Denmark. Frequent co-authors include Frank Tacke, Christoph Roderburg, Jürgen K. Rockstroh, Ulrich Spengler, Christian P. Strassburg, Maria A. González-Carmona, Tom Luedde, Jonel Trebicka, Münevver Demir and Leona Dold. Their work appears in journals such as PLoS ONE, Liver International, Journal of Clinical Medicine, International Journal of Molecular Sciences and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.